Labcorp Perspectives: Oncology podcast

Transforming Cancer Detection with Tissue-Free MRD

0:00
25:57
Rewind 15 seconds
Fast Forward 15 seconds

What if a single blood test could transform every stage of cancer care?

In this essential episode of Labcorp Perspectives Oncology, Dr. Rebecca Previs welcomes Dr. Anne-Renee Hartman, a pioneering oncologist and diagnostics leader, to share the latest breakthroughs in tissue-free, methylation-based MRD testing.

Explore how these blood-based assays are shaping decision-making across early detection, recurrence monitoring, and real-time treatment response—delivering value at every point in the cancer journey. Discover data, real-world implications, and why these tools could soon become a mainstay in oncology care.

Don’t miss this eye-opening conversation—tune in now.

Follow Us

Presented by Labcorp Oncology
https://www.labcorp.com/oncology


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

More episodes from "Labcorp Perspectives: Oncology"